Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer

Table 1

Relationships of NUCB2 and clinicopathological characteristics in 115 patients with BC.

Feature	All ()	NUCB2 expression
		Low	High
		Age (year)						2.184	0.139
<65	46	18	28
≥65	69	18	51
Gender				0.332	0.565
Male	99	30	69
Female	16	6	10
Tumor stage				0.208	0.648
T2	35	12	23
T3/T4	80	24	56
Tumor grade				1.408	0.235
Low	33	13	20
High	82	23	59
Lymph node metastasis				1.669	0.196
Yes	35	8	27
No	80	28	52
Recurrence				1.948	0.163
Yes	59	15	44
No	56	21	35
Distant metastasis				5.830	0.016
Yes	51	10	41
No	64	26	38
Vascular invasion				12.500	0.000
Yes	60	10	50
No	55	26	29

.